These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 29575809)
1. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway. Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809 [TBL] [Abstract][Full Text] [Related]
2. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells. Ge X; Peng X; Li M; Ji F; Chen J; Zhang D Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182 [TBL] [Abstract][Full Text] [Related]
3. Silencing of Zhang P; Li Z; Yang G Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300 [TBL] [Abstract][Full Text] [Related]
4. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway. Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510 [TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNAs (lncRNAs) Tumor-Suppressive Role of lncRNA on Chromosome 8p12 (TSLNC8) Inhibits Tumor Metastasis and Promotes Apoptosis by Regulating Interleukin 6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia-Inducible Factor 1-alpha (HIF-1α) Signaling Pathway in Non-Small Cell Lung Cancer. Fan H; Li J; Wang J; Hu Z Med Sci Monit; 2019 Oct; 25():7624-7633. PubMed ID: 31601776 [TBL] [Abstract][Full Text] [Related]
6. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway. Wang WP; Sun Y; Lu Q; Zhao JB; Wang XJ; Chen Z; Ni YF; Wang JZ; Han Y; Zhang ZP; Yan XL; Li XF Oncotarget; 2017 Jan; 8(4):5909-5923. PubMed ID: 27992365 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer. Zhao M; Liu Y; Liu R; Qi J; Hou Y; Chang J; Ren L Cell Physiol Biochem; 2018; 45(6):2213-2224. PubMed ID: 29550807 [TBL] [Abstract][Full Text] [Related]
8. DHA inhibits invasion and metastasis in NSCLC cells by interfering with CCL18/STAT3 signaling pathway. Luo HQ; Huang YM; Li J; Tang XD; Chen R; Wang Y; Ren J; Dai QQ; Lan LB; Chen JY; Li XY Clin Exp Med; 2023 Oct; 23(6):2311-2320. PubMed ID: 36217054 [TBL] [Abstract][Full Text] [Related]
9. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer. Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555 [TBL] [Abstract][Full Text] [Related]
10. IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling. Pu XY; Zheng DF; Shen A; Gu HT; Wei XF; Mou T; Zhang JB; Liu R Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):408-415. PubMed ID: 30201411 [TBL] [Abstract][Full Text] [Related]
11. Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway. Wang X; Wang Y; Xiao G; Wang J; Zu L; Hao M; Sun X; Fu Y; Hu G; Wang J Oncotarget; 2016 May; 7(21):30350-64. PubMed ID: 27107418 [TBL] [Abstract][Full Text] [Related]
12. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells. Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway. Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256 [TBL] [Abstract][Full Text] [Related]
14. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells. Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041 [TBL] [Abstract][Full Text] [Related]
15. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway. Zhu X; Guo X; Wu S; Wei L Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-212 suppresses nonsmall lung cancer invasion and migration by regulating ubiquitin-specific protease-9. Chen W; Huang Y; Zhang S; Zheng X; Xie S; Mao J; Cai Y; Lu X; Hu L; Shen J; Dong Y; Chai K J Cell Biochem; 2019 Apr; 120(4):6482-6489. PubMed ID: 30335901 [TBL] [Abstract][Full Text] [Related]
17. IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-κB. Liu W; Wang H; Bai F; Ding L; Huang Y; Lu C; Chen S; Li C; Yue X; Liang X; Ma C; Xu L; Gao L Cell Prolif; 2020 Mar; 53(3):e12776. PubMed ID: 32020709 [TBL] [Abstract][Full Text] [Related]
18. DAL-1 attenuates epithelial to mesenchymal transition and metastasis by suppressing HSPA5 expression in non-small cell lung cancer. Qiu X; Guan X; Liu W; Zhang Y Oncol Rep; 2017 Nov; 38(5):3103-3113. PubMed ID: 29048640 [TBL] [Abstract][Full Text] [Related]
19. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling. Geng F; Jiang Z; Song X; Zhou H; Zhao H Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479 [TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis. Zhou QX; Jiang XM; Wang ZD; Li CL; Cui YF Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]